| Acquired by | Abbott Labs |
| Price | $410M |
| Date | 9/09 |
| Website | evalveinc.com |
| Category | BioTech |
| Phone | 650-330-8100 |
| info@evalveinc.com | |
| Employees | |
| Founded | 1999 |
| Description | repair of cardiac valves |
| TOTAL | $60M |
| FUNDING TOTAL | $60M |
| Series D, 11/07 BBT Fund Delphi Ventures New Enterprise Associates Split Rock Partners Abbott Labs | $60M |
Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.
